Raju Prasad, CFO: Crispr Therapeutics CRSP Sell · Filed 25/12/23

Trade details

Type: Insider sale
Amount: $308,237.76
Shares · price: 5,472 sh · $56.33 a share
Held after: 7,767 sh
Stock: Crispr Therapeutics CRSP
Person: Raju PrasadCFO
Trade date: 25/12/22
Filed: 25/12/23
Days to filing: 1 days

Sold 41.3% of holdings

Share of holding sold: 41.3%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/22~01/21

Raju Prasad's recent trades

Raju PrasadCFO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$173.5K
3,708 sh
$173.5K
Filed 03/24
Traded 03/23
Raju PrasadCFO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$282.2K
5,848 sh
$282.2K
Filed 03/17
Traded 03/16
Raju PrasadCFO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$194.1K
4,021 sh
$194.1K
Filed 03/17
Traded 03/16
Raju PrasadCFO
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 plan
Crispr Therapeutics
CRSP
$2.1M
34,972 sh
$2.1M
Filed 01/26
Traded 01/22
Raju PrasadCFO
Planned sale10b5-1 planCrispr Therapeutics
Planned sale10b5-1 plan
Crispr Therapeutics
CRSP
$2.1M
34,972 sh
$2.1M
Filed 01/22
Traded 01/22